{"id":"reactive-focal-drug-administration","safety":{"commonSideEffects":[{"rate":"null","effect":"Local irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This method involves delivering a drug directly to the affected area, reducing systemic side effects and improving efficacy. The exact mechanism of action depends on the specific drug used, but it often involves the release of a therapeutic agent at the site of disease.","oneSentence":"Reactive focal drug administration is a treatment approach that targets specific areas of the body with a drug.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:04:04.831Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various cancers"}]},"trialDetails":[{"nctId":"NCT04898699","phase":"EARLY_PHASE1","title":"IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya","status":"COMPLETED","sponsor":"Columbia University","startDate":"2021-11-24","conditions":"HIV","enrollment":120},{"nctId":"NCT07380191","phase":"NA","title":"EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-21","conditions":"Fall Risk, Fall Prevention","enrollment":60},{"nctId":"NCT01665326","phase":"","title":"Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease","status":"RECRUITING","sponsor":"Duke University","startDate":"2009-09","conditions":"Pompe Disease","enrollment":400},{"nctId":"NCT05052502","phase":"NA","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","status":"UNKNOWN","sponsor":"University of California, San Francisco","startDate":"2020-11-01","conditions":"Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria","enrollment":49118},{"nctId":"NCT02315690","phase":"PHASE3","title":"Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-09","conditions":"Malaria","enrollment":4000},{"nctId":"NCT02653898","phase":"PHASE4","title":"Malaria Elimination Pilot Study in Military Forces in Cambodia","status":"UNKNOWN","sponsor":"Armed Forces Research Institute of Medical Sciences, Thailand","startDate":"2016-01","conditions":"Malaria, Parasitic Diseases","enrollment":1050},{"nctId":"NCT02654912","phase":"PHASE4","title":"Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration","status":"COMPLETED","sponsor":"PATH","startDate":"2016-02","conditions":"Malaria","enrollment":8682},{"nctId":"NCT04094727","phase":"PHASE4","title":"Malaria High-Risk Populations in Namibia","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-10-31","conditions":"Malaria","enrollment":3302},{"nctId":"NCT02610400","phase":"PHASE3","title":"Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-02","conditions":"Malaria","enrollment":9845},{"nctId":"NCT02397369","phase":"NA","title":"Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2015-03","conditions":"Compliance, Tobacco Use Cessation","enrollment":4000},{"nctId":"NCT02536222","phase":"PHASE4","title":"Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts","status":"COMPLETED","sponsor":"PATH","startDate":"2015-09","conditions":"Malaria","enrollment":20379},{"nctId":"NCT01575613","phase":"NA","title":"Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2012-04","conditions":"Malaria","enrollment":17506},{"nctId":"NCT01152931","phase":"PHASE3","title":"Antioxidant Micronutrients in Malaria","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2010-08","conditions":"Malaria","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Reactive Focal Drug Administration","genericName":"Reactive Focal Drug Administration","companyName":"PATH","companyId":"path","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Reactive focal drug administration is a treatment approach that targets specific areas of the body with a drug. Used for Treatment of various cancers.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}